Delphi Management Partners VIII

Latest statistics and disclosures from Delphi Management Partners VIII's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are TNDM, KPTI, Calithera Biosciences, MREO, and represent 100.00% of Delphi Management Partners VIII's stock portfolio.
  • Delphi Management Partners VIII has $139M in assets under management (AUM), dropping by 9.33%.
  • Central Index Key (CIK): 0001457494

Tip: Access up to 7 years of quarterly data

Positions held by Delphi Management Partners VIII consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Delphi Management Partners VIII

Delphi Management Partners VIII holds 4 positions in its portfolio as reported in the September 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Tandem Diabetes Common Stock (TNDM) 86.2 $119M 1.0M 119.38
 View chart
Karyopharm Therapeutics Common Stock (KPTI) 9.5 $13M 2.3M 5.82
 View chart
Calithera Biosciences Common Stock 3.8 $5.3M 2.4M 2.18
 View chart
Mereo BioPharma Group Ads (MREO) 0.4 $621k 257k 2.42
 View chart

Past Filings by Delphi Management Partners VIII

SEC 13F filings are viewable for Delphi Management Partners VIII going back to 2019